Form D · Other Health Care
Transcarent, Inc.
Denver, CO · CIK 0002065307
Offering snapshot reported Apr 22, 2025 · SEC filing
- Reported sold
- $481M Offering amount: $700M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 22, 2025 | Initial | $480,999,962 | No comparison | 33 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-544249
Source: Form D, filed Apr 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Erica Davila | Executive |
| Ken Frazier | Director |
| Holly Maloney | Director |
| Stephanie Peng | Executive |
| Lee Shapiro | Director, Executive |
| Hemant Taneja | Director |
| Glen Tullman | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
4700 S. Syracuse Street Suite 900
Denver, CO, 80237
Denver, CO, 80237